Status:
COMPLETED
Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis
Lead Sponsor:
Basilea Pharmaceutica
Conditions:
Hand Dermatoses
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
Patients with severe chronic hand dermatitis, that has not responded to topical treatment, including topical steroids and the avoidance of aggravating factors, will be treated with the oral medication...
Detailed Description
For severe, chronic hand dermatitis, refractory to topical treatment and the avoidance of aggravating factors such as allergens and irritants, no registered systemic treatment is available. Current sy...
Eligibility Criteria
Inclusion
- Chronic hand dermatitis, rated as severe by physicians global assessment, present for at least 6 months, that has not responded to the avoidance of allergens and irritants and the use of topical steroids
Exclusion
- female of childbearing potential, unless participating in a pregnancy prevention program
- psoriasis
- active major psychiatric condition
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
End Date :
May 1 2007
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00309621
Start Date
April 1 2006
End Date
May 1 2007
Last Update
May 10 2023
Active Locations (33)
Enter a location and click search to find clinical trials sorted by distance.
1
Edmonton, Alberta, Canada, T6G2G3
2
Vancouver, British Columbia, Canada, V5O3Y1
3
Winnipeg, Manitoba, Canada, R3C1R4
4
Hawkesbury, Ontario, Canada, K6A1A1